The Institute for Translational Neuroscience's greatest strength is bringing together different groups under one common goal: to advance neuroscience research at the University of Minnesota.
The Institute for Translational Neuroscience (ITN) was established in 2007 as a University-wide presidential initiative to promote the transfer of discoveries in the basic neurosciences to clinical practice. The institute is charged to enhance basic science discovery with new knowledge leading to subsequent clinical trials and establishment of new therapeutic principles or tools.
Our main goal is to attract and recruit top scientists to shape discoveries that will lead to tomorrow's cures. The institute exemplifies how different disciplines, departments, and centers can work together in partnership to evolve neurological disease research at the University of Minnesota. We have built a community that encourages learning, education, innovation, and discovery all of which are more successful in a team-oriented environment.
These world-class centers embrace and advance the institute's mission:
ITN in the News - ITN Director Harry Orr featured profile in The Lancet Neurology
ITN Director Harry Orr, Ph.D., will be profiled in an upcoming edition of The Lancet Neurology as part of their "In Context" feature, entitled "Harry T. Orr: decoding spinocerebellar ataxias." The profile is viewable online at The Lancet Neurology''s website in advance of print publication. The profile details Dr. Orr's career path to neurobiology and researching the genetic cause of spinocerebellar ataxia type 1, as well as the fruitful collaboration that led to the discovery of the ATXN1 gene, and the current work being done by Dr. Orr's lab at the University of Minnesota.
- The profile can be accessed online at The Lancet Neurology website.